These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4999088)

  • 21. The presence of antibody to Chikungunya and other serologically related viruses in the sera of sub-human primate imports to the United States.
    Harrison VR; Marshall JD; Guilloud NB
    J Immunol; 1967 May; 98(5):979-81. PubMed ID: 4960851
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on rinderpest culture vaccine. II. Factors influencing the accuracy of vaccine potency tests.
    Plowright W; Herniman KA; Rampton CS
    Res Vet Sci; 1969 Nov; 10(6):502-8. PubMed ID: 5392352
    [No Abstract]   [Full Text] [Related]  

  • 23. Japanese B encephalitis virus vaccines from tissue culture. VII. Formalin inactivated Nakayama strain vaccine.
    Darwish MA; Hammon WM
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):813-6. PubMed ID: 4288256
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 25. The response to measles and distemper virus in immuno-suppressed and normal dogs.
    Slater EA
    J Am Vet Med Assoc; 1970 Jun; 156(12):1762-6. PubMed ID: 5422526
    [No Abstract]   [Full Text] [Related]  

  • 26. Characteristics of primary cultures and diploid cells--technology of production.
    Holper JC
    Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
    [No Abstract]   [Full Text] [Related]  

  • 27. Intranuclear inclusions in milker's nodules.
    Evins S; Leavell UW; Phillips IA
    Arch Dermatol; 1971 Jan; 103(1):91-3. PubMed ID: 4321804
    [No Abstract]   [Full Text] [Related]  

  • 28. Yellow fever vaccine. IV. Reactogenicity and antibody response in volunteers inoculated with a vaccine free from contaminating avian leukosis viruses.
    Tauraso NM; Coultrip RL; Legters LJ; Richman AV; Rosenberg DM; Savadge TO; Shelokov A; Spector SL; Trimmer RW
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):439-46. PubMed ID: 4333781
    [No Abstract]   [Full Text] [Related]  

  • 29. The laboratory control of viral vaccines.
    Perkins FT
    Prog Immunobiol Stand; 1967; 3():225-31. PubMed ID: 4985509
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccines produced in heteroploid cell lines--discussion.
    Hull RN
    Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of local immunity after vaccination with live and killed virus].
    Pontecorvo M; Lombardi D
    Riv Ist Sieroter Ital; 1966; 41(4):264-72. PubMed ID: 5990412
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological and antigenic analyses of newly isolated strains of Echovirus type 7.
    Oishi I; Otsu K; Kunita N
    Biken J; 1971 Jun; 14(2):141-8. PubMed ID: 5001134
    [No Abstract]   [Full Text] [Related]  

  • 33. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of cell cultures in vaccine production: diploid and stable cell cultures.
    Matchett A
    J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of formalin on antigenic properties of influenza virus].
    Zgorzelska K; Wilczyński J
    Med Dosw Mikrobiol; 1980; 32(2):103-11. PubMed ID: 7464350
    [No Abstract]   [Full Text] [Related]  

  • 36. Latent viral infections in donor tissues and in recipients of vaccines.
    Melnick JL
    Natl Cancer Inst Monogr; 1968 Dec; 29():337-49. PubMed ID: 4305432
    [No Abstract]   [Full Text] [Related]  

  • 37. Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates--discussion.
    Stevenson RE
    Natl Cancer Inst Monogr; 1968 Dec; 29():333-4. PubMed ID: 4976361
    [No Abstract]   [Full Text] [Related]  

  • 38. SV40 neutralizing antibodies in the sera of man and experimental animals.
    Horváth LB
    Acta Virol; 1972 Mar; 16(2):141-6. PubMed ID: 4401071
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newcastle disease virus: evaluation of an avirulent enteric isolate as a viable vaccine.
    Beard CW
    Avian Dis; 1971; 15(2):334-41. PubMed ID: 5582057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.